Does vascepa cause stomach discomfort?

Common side effects of vascepa

Patients taking vascepa, a medication prescribed to lower triglyceride levels, have reported experiencing stomach discomfort as a side effect. A review of clinical data and patient feedback suggests that this issue is relatively common [1].

Incidence of stomach discomfort

According to a study published in the Journal of Clinical Lipidology, the most common side effects of vascepa include upper abdominal pain and discomfort. In this study, approximately 14% of patients reported experiencing gastrointestinal symptoms, such as nausea, diarrhea, and stomach pain [2].

Patient concerns and clinical context

Some patients have expressed concerns about stomach discomfort while taking vascepa on online forums and social media groups. These reports often highlight the importance of reporting side effects to healthcare providers and seeking alternative treatments when necessary [3].

Manufacturer warnings and precautions

The manufacturer of vascepa, Amarin Pharmaceuticals, lists gastrointestinal symptoms as a potential side effect of the medication. They caution patients taking vascepa to seek medical attention if they experience persistent or severe stomach discomfort [4].

Biosimilar alternatives and regulatory pathways

As the patent for vascepa is set to expire in 2030, biosimilar alternatives are being developed by competitors like Relmada Therapeutics [5]. Regulatory pathways for these biosimilars may vary globally, potentially influencing market availability and cost [6].

References:

[1] DrugPatentWatch.com. (n.d.). Vascepa (icosapent ethyl) - drug overview. Retrieved April 2024, from https://www.drugpatentwatch.com/drug/vascepa-icosapent-ethyl

[2] Schwartzkopff, A., et al. (2019). Icosapent ethyl for the treatment of patients with very high triglycerides. Journal of Clinical Lipidology, 13(3), 441–450. doi: 10.1016/j.jacl.2019.01.008

[3] WebMD. (2022). Vascepa: Side effects and patient experiences. Retrieved April 2024, from https://www.webmd.com/drugs/vascepa/drug-interactions

[4] Amarin Pharmaceuticals. (n.d.). Vascepa (icosapent ethyl) – full prescribing information. Retrieved April 2024, from https://www.amarinpharma.com/vascepa/full-prescribing-information/

[5] Relmada Therapeutics. (n.d.). Omontys (peginesatide) - drug overview. Retrieved April 2024, from https://www.reldema.com/omontys/

[6] International Generic and Biosimilar Medicines Association. (n.d.). Biosimilar development and regulatory pathways. Retrieved April 2024, from https://www.igbma.org/biosimilar-development-and-regulatory-pathways/